SCHEMBL7883223

SCHEMBL7883223

COC(=O)C1C(=O)CCc2c1ccc1c2OCO1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.40
NQO2 P16083 1/20 0.40
GAA P10253 2/20 0.38
CYP2D6 P10635 6/20 0.38
CYP2C19 P33261 6/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 3/20 0.36
CYP3A4 P08684 5/20 0.36
TSHR P16473 3/20 0.36
LMNA P02545 3/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
DRD2 P14416 1/20 0.36
HTR2A P28223 1/20 0.36
DRD3 P35462 1/20 0.36
MGAM O43451 1/20 0.36
AMY1A P0DUB6 1/20 0.36
SI P14410 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11957289 0.85 CYP2D6 (0.36) GAACYP2D6CYP2C19MEN1KMT2A
SCHEMBL7880454 0.78 ADRA2A (0.41) GAAMEN1KMT2AKDM4EALDH1A1
SCHEMBL11979078 0.77 GAA (0.39) GAAKDM4EALDH1A1NPC1RAB9A
SCHEMBL11979090 0.75 GAA (0.36) GAAKDM4EALDH1A1NPC1RAB9A
SCHEMBL8501452 0.74 CYP2D6 (0.35) CYP19A1NQO2GAACYP2D6CYP2C19
SCHEMBL50426 0.72 KDM4E (0.49) NQO2GAAKMT2AKDM4EALDH1A1
SCHEMBL5567729 0.68 KDM4E (0.36) GAACYP2D6CYP2C19MEN1KMT2A
SCHEMBL2597463 0.67 BRD4 (0.45) CYP2C19KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL17726240 0.67 GAA (0.47) GAACYP2D6CYP2C19MEN1KMT2A
SCHEMBL9814122 0.67 KCNH2 (0.39) GAACYP2D6CYP2C19MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120196889-A1 CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF H. LUNDBECK A/S (DK) 2012-08-02 US disclosed
WO-2010097087-A1 CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF H. LUNDBECK A/S (DK) 2010-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196889-A1 CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF COMT, ADRB3, ADRB1 CYP19A1 185/4885NQO2 477/4885GAA 653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.